Meta-analytic methods are essential for quantitative evidence synthesis, offering a statistical framework for model comparison and heterogeneity assessment. This paper revisits our previous work through a concise methodological review and model-comparison metaanalysis, illustrating adaptive model selection for binary outcomes. Thirteen studies (>6,000 patients) comparing monotherapy and combination regimens in metastatic melanoma immunotherapy were analyzed. Binary outcomes (benefit and risk rates) were pooled using fixed-effects (FEM), random-effects (REM), and generalized linear mixed models (GLMM), depending on heterogeneity. The results highlight how model choice influences pooled estimates and inference reliability, underscoring the importance of flexible statistical modeling in complex datasets.